Multi-omics profiling of longitudinal samples reveals early genomic changes in follicular lymphoma.
Baoyan BaiJillian F WiseDaniel VodákSigve NakkenAnkush SharmaYngvild Nuvin BlakerMarianne BrodtkorbVera HildenGunhild TrøenWeicheng RenSusanne LorenzMichael S LawrenceOla MyklebostEva KimbyQiang Pan-HammarströmChloé B SteenLeonardo A Meza-ZepedaKlaus BeiskeErlend B SmelandEivind HovigOle Christian LingjærdeHarald HolteJune Helen MyklebustPublished in: Blood cancer journal (2024)
Follicular lymphoma (FL) is the most common indolent type of B-cell non-Hodgkin lymphoma. Advances in treatment have improved overall survival, but early relapse or transformation to aggressive disease is associated with inferior outcome. To identify early genetic events and track tumor clonal evolution, we performed multi-omics analysis of 94 longitudinal biopsies from 44 FL patients; 22 with transformation (tFL) and 22 with relapse without transformation (nFL). Deep whole-exome sequencing confirmed recurrent mutations in genes encoding epigenetic regulators (CREBBP, KMT2D, EZH2, EP300), with similar mutational landscape in nFL and tFL patients. Calculation of genomic distances between longitudinal samples revealed complex evolutionary patterns in both subgroups. CREBBP and KMT2D mutations were identified as genetic events that occur early in the disease course, and cases with CREBBP KAT domain mutations had low risk of transformation. Gains in chromosomes 12 and 18 (TCF4), and loss in 6q were identified as early and stable copy number alterations. Identification of such early and stable genetic events may provide opportunities for early disease detection and disease monitoring. Integrative analysis revealed that tumors with EZH2 mutations exhibited reduced gene expression of numerous histone genes, including histone linker genes. This might contribute to the epigenetic dysregulation in FL.